全文获取类型
收费全文 | 2784篇 |
免费 | 158篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 74篇 |
妇产科学 | 62篇 |
基础医学 | 490篇 |
口腔科学 | 103篇 |
临床医学 | 236篇 |
内科学 | 541篇 |
皮肤病学 | 33篇 |
神经病学 | 285篇 |
特种医学 | 114篇 |
外科学 | 224篇 |
综合类 | 19篇 |
预防医学 | 259篇 |
眼科学 | 30篇 |
药学 | 218篇 |
中国医学 | 22篇 |
肿瘤学 | 250篇 |
出版年
2024年 | 2篇 |
2023年 | 36篇 |
2022年 | 100篇 |
2021年 | 139篇 |
2020年 | 89篇 |
2019年 | 89篇 |
2018年 | 98篇 |
2017年 | 84篇 |
2016年 | 96篇 |
2015年 | 79篇 |
2014年 | 135篇 |
2013年 | 157篇 |
2012年 | 254篇 |
2011年 | 243篇 |
2010年 | 130篇 |
2009年 | 131篇 |
2008年 | 183篇 |
2007年 | 184篇 |
2006年 | 167篇 |
2005年 | 139篇 |
2004年 | 86篇 |
2003年 | 117篇 |
2002年 | 97篇 |
2001年 | 15篇 |
2000年 | 8篇 |
1999年 | 11篇 |
1998年 | 11篇 |
1997年 | 10篇 |
1995年 | 13篇 |
1994年 | 5篇 |
1993年 | 10篇 |
1992年 | 6篇 |
1991年 | 3篇 |
1990年 | 7篇 |
1989年 | 2篇 |
1988年 | 2篇 |
1986年 | 2篇 |
1985年 | 3篇 |
1984年 | 3篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1980年 | 3篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1973年 | 1篇 |
1972年 | 2篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1964年 | 1篇 |
1932年 | 1篇 |
排序方式: 共有2969条查询结果,搜索用时 15 毫秒
101.
Palmerini T Coller BS Cervi V Tomasi L Marzocchi A Marrozzini C Leone O Piccioli M Branzi A 《Journal of the American College of Cardiology》2004,44(8):1570-1577
OBJECTIVES: This study evaluated the role of circulating tissue factor (TF) in mediating thrombus formation on stents in an in vitro model of stent perfusion. BACKGROUND: The traditional view of coagulation has recently been challenged by the demonstration that TF is present in circulating blood. The potential contribution of this intravascular pool of TF to thrombus formation on stents is not known. METHODS: Coronary stents were placed in parallel silicone tubes connected to a roller pump that was set to pump blood at a flow rate of 10 ml/min. Stents were then exposed to heparinized blood from healthy volunteers for 120 min. RESULTS: The presence of the stent in the circuit caused a significant increase in monocyte TF expression, but only monocytes with attached platelets stained positive for TF. Thrombi formed on stents and the thrombi stained positive for TF. Pretreatment of blood with a monoclonal antibody against TF (cH36) caused a 56% reduction in (125)I-fibrin(ogen) deposition on stents compared with controls (p = 0.002). Monocyte depletion of blood reduced (125)I-fibrin(ogen) deposition by 45% (p = 0.01) and TF staining in the thrombus by 83% (p = 0.01). Pretreatment of blood with a monoclonal antibody against P-selectin reduced (125)I-fibrin(ogen) deposition by 24% (p = 0.04). Perfusion of stents with leukocyte-reduced platelet-rich plasma (PRP) produced small thrombi and treatment of PRP with cH36 reduced (125)I-fibrin(ogen) deposition by 43% (p = 0.01). CONCLUSIONS: Circulating TF plays a pivotal role in thrombus formation on stents. Monocytes appear to be the main, but not only, source of TF depositing in the thrombus. 相似文献
102.
Francesca Veronesi Stefania Pagani Elena Della Bella Gianluca Giavaresi Milena Fini 《Age (Dordrecht, Netherlands)》2014,36(3):1225-1238
Osteoporosis due to estrogen deficiency is an increasing bone health issue worldwide: new strategies are being studied for regenerative medicine of bone pathologies in these patients. The most commonly used cells for tissue engineering therapy are the bone marrow mesenchymal stem cells (BMSCs), but they might be negatively affected by aging and estrogen deficiency. Besides the general advantages of adipose-derived mesenchymal stem cells (ADSCs) over BMSCs, ADSCs also seem to be less affected by aging than BMSCs, but in the literature, little is known about ADSCs in estrogen deficiency. The present study investigated the in vitro behavior of ADSCs, isolated from healthy (SHAM) and estrogen-deficient (OVX) rats. Phenotype, clonogenicity, viability, and osteogenic differentiation, at both cellular and molecular levels, were evaluated with or without osteogenic stimuli. Pro-inflammatory cytokines, growth factors, and adipogenic differentiation markers were also analyzed. There were no significant differences between OVX and SHAM ADSCs in some analyzed parameters. In addition, clonogenicity, osteopontin (Spp1) gene expression, alkaline phosphatase (ALP) activity at 2 weeks of culture, total collagen (COLL), osteocalcin (Bglap) gene expression and production, and matrix mineralization were significantly higher in OVX than in SHAM ADSCs. Besides the increase in some osteogenic markers, peroxisome proliferator-activated receptor gamma (Pparg) gene was also more expressed in OVX in osteogenic medium, with a concomitant estrogen receptor 1 (Esr1) gene expression decrease. These results underlined that ADSCs were not affected by estrogen deficiency in an osteogenic microenvironment. 相似文献
103.
104.
105.
BCR‐ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next‐generation sequencing 下载免费PDF全文
106.
Roberto Grimaldi Marta Bisi Enrica Lonni Eloise Beggiato Alessandra Valpreda Marco Francesco Lococo Enrico Dosio Davide Giacomo Presutti Milena Tagliabue Fiorenzo Gaita 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》2014,28(4):323-329
Purpose
Aspirin resistance occurs most frequently in diabetic patients and is associated with poor prognosis. The purpose of this study was to evaluate the prevalence of aspirin resistance in a cohort of diabetic patients and whether it can be reversed using more bioavailable aspirin formulations.Methods
Platelets function of 163 diabetic patients taking acetyl salicylic acid (ASA) 100 mg daily has been evaluated with PFA100 and VerifyNow. Patients found resistant by at least one test received an infusion of 288 mg of lysine acetylsalicylate (Flectadol®) corresponding to ASA 160 mg. Platelets function was measured again after 1 and 24 h. Patients whose the resistance was reversed received 288 mg of soluble salt of lysine acetylsalicylate (Cardirene 160®) corresponding to ASA160 mg instead of aspirin and their aggregation status was re-evaluated after 1 month of therapy.Results
Prevalence of aspirin resistance in our population was 18,4 % (30/163). In 27 out of 30 patients (90 %) aspirin resistance was reversed within 24 h from the infusion. 25 out of 27 patients (92 %) were found fully aspirin-sensitive after 1 month of oral therapy with soluble salt; two patients were found with borderline value. No adverse reactions were observed.Conclusions
A significant number of diabetic patients are resistant to aspirin therapy. A single intravenous dose of lysine acetylsalicylate can reverse the platelet hyper-aggregability and laboratory aspirin resistance in large majority of patients. The efficacy of antiaggregation can be maintained by chronic therapy with an oral drug with a more favourable pharmacokinetic profile. 相似文献107.
108.
Laura Avagliano Ilaria Parenti Paolo Grazioli Elisabetta Di Fede Chiara Parodi Milena Mariani Frank J. Kaiser Angelo Selicorni Cristina Gervasini Valentina Massa 《Clinical genetics》2020,97(1):3-11
In recent years, many genes have been associated with chromatinopathies classified as “Cornelia de Lange Syndrome-like.” It is known that the phenotype of these patients becomes less recognizable, overlapping to features characteristic of other syndromes caused by genetic variants affecting different regulators of chromatin structure and function. Therefore, Cornelia de Lange syndrome diagnosis might be arduous due to the seldom discordance between unexpected molecular diagnosis and clinical evaluation. Here, we review the molecular features of Cornelia de Lange syndrome, supporting the hypothesis that “CdLS-like syndromes” are part of a larger “rare disease family” sharing multiple clinical features and common disrupted molecular pathways. 相似文献
109.
Carina Venter Matthew Greenhawt Rosan W. Meyer Carlo Agostoni Imke Reese George du Toit Mary Feeney Kate Maslin Bright I. Nwaru Caroline Roduit Eva Untersmayr Berber Vlieg-Boerstra Isabella Pali-Schöll Graham C. Roberts Peter Smith Cezmi A. Akdis Ioana Agache Miriam Ben-Adallah Stephan Bischoff Remo Frei Holger Garn Kate Grimshaw Karin Hoffmann-Sommergruber Nonhlanhla Lunjani Antonella Muraro Lars K. Poulsen Harald Renz Milena Sokolowska Catherine Stanton Liam O'Mahony 《Allergy》2020,75(3):497-523
To fully understand the role of diet diversity on allergy outcomes and to set standards for conducting research in this field, the European Academy of Allergy and Clinical Immunology Task Force on Diet and Immunomodulation has systematically explored the association between diet diversity and allergy outcomes. In addition, a detailed narrative review of information on diet quality and diet patterns as they pertain to allergic outcomes is presented. Overall, we recommend that infants of any risk category for allergic disease should have a diverse diet, given no evidence of harm and some potential association of benefit in the prevention of particular allergic outcomes. In order to harmonize methods for future data collection and reporting, the task force members propose relevant definitions and important factors for consideration, when measuring diet diversity in the context of allergy. Consensus was achieved on practice points through the Delphi method. It is hoped that the definitions and considerations described herein will also enable better comparison of future studies and improve mechanistic studies and pathway analysis to understand how diet diversity modulates allergic outcomes. 相似文献
110.